Pulmonx Corp cotiza a 1.76 USD y tiene una capitalización bursátil de $76M. En los últimos 12 meses ha facturado $87M con un margen de flujo de caja libre del -36.3%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Pulmonx Corporation, a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease. It offers Zephyr Endobronchial Valve; and Chartis Pulmonary Assessment System, a balloon catheter and console system with f…
| Métrica | LUNG | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 74.2% | 57.0% | +17.1% |
| Operating Margin | -59.3% | -38.6% | -20.7% |
| Net Margin | -59.7% | -33.6% | -26.1% |
| FCF Margin | -36.3% | -13.9% | -22.4% |
| ROE | -99.8% | -40.4% | -59.4% |
| ROA | -41.8% | -32.0% | -9.8% |
| Current Ratio | 5.07 | 2.84 | +2.23 |
| Debt / Equity | 0.69 | 0.28 | +0.41 |